- Home
- TCRX vs WHG Comparison
TCRX vs WHG Comparison
Compare TCRX & WHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- WHG
- Stock Information
- Founded
- TCRX 2018
- WHG 1983
- Country
- TCRX United States
- WHG United States
- Employees
- TCRX N/A
- WHG N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- WHG Investment Managers
- Sector
- TCRX Health Care
- WHG Finance
- Exchange
- TCRX Nasdaq
- WHG Nasdaq
- Market Cap
- TCRX 140.7M
- WHG 161.0M
- IPO Year
- TCRX 2021
- WHG 2002
- Fundamental
- Price
- TCRX $1.89
- WHG $16.14
- Analyst Decision
- TCRX Strong Buy
- WHG
- Analyst Count
- TCRX 5
- WHG 0
- Target Price
- TCRX $9.40
- WHG N/A
- AVG Volume (30 Days)
- TCRX 656.4K
- WHG 6.0K
- Earning Date
- TCRX 11-07-2025
- WHG 10-30-2025
- Dividend Yield
- TCRX N/A
- WHG 3.69%
- EPS Growth
- TCRX N/A
- WHG 154.57
- EPS
- TCRX N/A
- WHG 0.82
- Revenue
- TCRX $6,961,000.00
- WHG $96,243,000.00
- Revenue This Year
- TCRX $255.18
- WHG N/A
- Revenue Next Year
- TCRX N/A
- WHG N/A
- P/E Ratio
- TCRX N/A
- WHG $39.00
- Revenue Growth
- TCRX N/A
- WHG 4.20
- 52 Week Low
- TCRX $1.02
- WHG $13.49
- 52 Week High
- TCRX $6.23
- WHG $18.97
- Technical
- Relative Strength Index (RSI)
- TCRX 39.56
- WHG 36.80
- Support Level
- TCRX $1.74
- WHG $16.17
- Resistance Level
- TCRX $2.43
- WHG $16.50
- Average True Range (ATR)
- TCRX 0.18
- WHG 0.20
- MACD
- TCRX -0.07
- WHG 0.00
- Stochastic Oscillator
- TCRX 14.46
- WHG 0.00
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About WHG Westwood Holdings Group Inc
Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.